Genetic polymorphisms in carcinogen detoxifying genes and risk of cervical cancer in Maharashtra, India: a case control study.

Polymorphism in GSTM1, GSTT1, GSTP1 and cervical cancer in Maharashtra

Authors

  • Kailas D Datkhile Krishna Institute of Medical Sciences
  • Madhavi N Patil Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Pratik P Durgawale Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Kalpita S Korabu Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Shreepad A Joshi Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences
  • Anand Gudur Department of Oncology, Krishna Institute of Medical Sciences
  • Rashmi A Gudur Department of Oncology, Krishna Institute of Medical Sciences
  • Satish V Kakade Department of Preventive & Social Medicine, Krishna Institute of Medical Sciences

DOI:

https://doi.org/10.7439/ijbr.v10i4.5105

Keywords:

Cervical Cancer, GSTM1, GSTT1, GSTP1, Genetic Polymorphism, PCR-RFLP

Abstract

Objectives: To explore the association of genetic polymorphisms in individual or combined genotypes of GSTM1, GSTT1 and GSTP1 with cervical cancer (CC) susceptibility in women from Maharashtra.

Methods: The polymorphisms in GSTM1 and GSTT1 were analyzed by polymerase chain reaction (PCR) and GSTP1 by polymerase chain reaction - Restriction Fragment Length Polymorphism (PCR-RFLP) in 350 CC cases and 400 healthy controls.

Results: In this study we found GSTM1 and GSTT1 as risk factors with significant association with null (-/-) genotypes of M1 and T1 with increasing the risk of CC by 1.41 and 1.46 folds respectively. GSTM1 (-/-) null genotype was prominent among cases (36.29%) indicating contributory risk factor for development of CC (OR=1.41; 95% CI: 1.03-1.91; p=0.02), GSTT1 null increases in CC cases (OR=1.46, 95% CI: 1.04-2.06; p=0.02). The combined analysis of GSTM1 (-/-) / GSTT1 (-/-) showed 2.27 folds higher risk of development of CC (OR=2.27, 95% CI: 1.25-4.09; p=0.005), whereas, combinations of GSTP1 genotype (A/G +G/G) of exon 5 with GSTM1 null, which showed 1.92 fold risk of CC (OR=1.92, 95% CI: 1.21-3.04; p=0.005) and combination of (C/T +T/T) genotype of GSTP1 exon 6 with GSTM1 (-/-) null did not show any association with development of CC (OR=0.81, 95% CI: 0.52-1.25; p=0.35). Triple combinations of GSTM1, T1 null and P1 (A/G or G/G) genotypes showed significant association (p=0.005) with a 3.04 times risk of developing CC.

Conclusions: This investigation affirms the conceivable interactions between GST polymorphisms and development of cervical cancer in rural population of south western Maharashtra from India.

Downloads

Downloads

Published

2019-04-28

Issue

Section

Original Research Articles

How to Cite

1.
Genetic polymorphisms in carcinogen detoxifying genes and risk of cervical cancer in Maharashtra, India: a case control study.: Polymorphism in GSTM1, GSTT1, GSTP1 and cervical cancer in Maharashtra. Int Jour of Biomed Res [Internet]. 2019 Apr. 28 [cited 2025 Jul. 24];10(4):e5105. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/5105